Temazepam - An Overview

Temazepam - An Overview

Blog Article

nirmatrelvir will enhance the stage or effect of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.

  The believed background threat of important beginning defects and miscarriage for that indicated inhabitants is unknown. All pregnancies Have a very history risk of beginning defect, reduction, or other adverse outcomes.

Observe Intently (1)mitotane decreases levels of triazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of. Mitotane is a robust inducer of cytochrome P-4503A4; watch when coadministered with CYP3A4 substrates for doable dosage adjustments.

efavirenz will lessen the extent or result of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.

eslicarbazepine acetate will minimize the extent or outcome of triazolam by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.

Keep track of Intently (one)ethinylestradiol will improve the amount or outcome of triazolam by System: lowering metabolism.

Reserve concomitant prescribing of those medicines in patients for whom other therapy solutions are inadequate. Limit dosages and durations to the bare minimum demanded. Monitor closely for signs of respiratory depression and sedation.

aprepitant will raise the amount or influence of triazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.

ribociclib will enhance the amount or impact of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

berotralstat will boost the amount or impact of triazolam by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. Keep an eye on or titrate substrate dose when berotralstat is coadministered with narrow therapeutic index medicine which can be CYP3A substrates.

Take into account decreasing the dose from the sensitive CYP3A4 substrate and keep an eye on for indications of toxicities with the coadministered delicate CYP3A substrate.

Withdrawal Reactions Inform clients that the ongoing usage of estazolam may perhaps result in clinically important Actual physical dependence and that abrupt discontinuation or speedy dosage reduction of estazolam might precipitate acute withdrawal reactions, that may be daily life-threatening.

artemether/lumefantrine will reduce the extent or impact of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.

Our highly-specialised educational courses shape leaders to generally be with the forefront of cancer care and Trazodone research.